Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,276,026,041
+$131,067,127 QoQ
Shares Held
5,024,318
+7.3% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#53
of 4,647 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $6,692,750,905 across 9 Drug Manufacturers - General names. JNJ ranks #2 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,477,275 | $1,771,888,099 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
5,024,318 | $1,276,026,041 | |
| 3 | ABBV |
AbbVie Inc.
|
4,805,342 | $1,209,216,259 | |
| 4 | AMGN |
Amgen Inc
|
2,239,516 | $810,973,532 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,152,239 | $650,933,874 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,052,294 | $463,973,179 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,503,750 | $450,231,874 | |
| 8 | PFE |
Pfizer Inc
|
2,318,237 | $55,823,144 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,276,026,041 | 5,024,318 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $1,144,958,914 | 4,684,008 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,130,040,540 | 5,460,452 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $1,132,890,424 | 6,109,861 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $956,101,811 | 6,259,259 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $1,067,909,762 | 6,439,398 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $929,136,496 | 6,424,675 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $915,506,919 | 5,649,185 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $942,708,906 | 6,449,842 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $1,210,788,790 | 7,654,016 | Shares | Defined | 2024-05-02 | |
| 2023-12-31 | $1,249,034,570 | 7,968,831 | Shares | Defined | 2024-01-10 | |
| 2023-09-30 | $1,348,920,222 | 8,660,804 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,521,305,740 | 9,191,069 | Shares | Defined | 2023-07-07 | |
| 2023-03-31 | $1,119,385,045 | 7,221,839 | Shares | Defined | 2023-04-19 | |
| 2022-12-31 | $1,263,504,316 | 7,152,586 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,354,525,413 | 8,291,659 | Shares | Defined | 2022-10-19 | |
| 2022-06-30 | $1,524,140,088 | 8,586,221 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $1,622,031,644 | 9,152,128 | Shares | Defined | 2022-04-11 | |
| 2021-12-31 | $1,776,680,159 | 10,385,691 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $1,593,897,441 | 9,869,334 | Shares | Defined | 2021-11-01 | |
| 2021-06-30 | $1,579,987,073 | 9,590,792 | Shares | Defined | 2021-07-16 | |
| 2021-03-31 | $1,541,343,491 | 9,378,421 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,397,072,174 | 8,877,063 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,281,845,634 | 8,609,925 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,421,952,642 | 17,222,162 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,201,145,292 | 9,159,958 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||